CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-09 | Elston George Chief Financial Officer | Option exercise | +5,833 | 18,149 | ||
| 2023-02-09 | Elston George Chief Financial Officer | Option exercise | +4,967 | 23,116 | ||
| 2023-02-09 | Elston George Chief Financial Officer | Option exercise · Restricted Stock Units | −5,833 | 11,667 | ||
| 2023-02-09 | Elston George Chief Financial Officer | Option exercise · Restricted Stock Units | −4,967 | 4,967 | ||
| 2023-02-09 | Lurker Nancy CEO | Option exercise | +17,533 | 170,559 | ||
| 2023-02-09 | Lurker Nancy CEO | Option exercise | +20,000 | 190,559 | ||
| 2023-02-09 | Lurker Nancy CEO | Option exercise · Restricted Stock Units | −20,000 | 40,000 | ||
| 2023-02-09 | Lurker Nancy CEO | Option exercise · Restricted Stock Units | −17,533 | 17,534 | ||
| 2023-01-06 | Lurker Nancy CEO | Grant or award · Stock Option (Right to Buy) | +450,800 | 450,800 | ||
| 2023-01-06 | Duker Jay S. President and COO | Grant or award · Stock Option (Right to Buy) | +124,755 | 124,755 | ||
| 2023-01-06 | Elston George Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +91,655 | 91,655 | ||
| 2023-01-06 | Jones David Scott SVP & Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +91,655 | 91,655 | ||
| 2023-01-06 | Pine Michael Craig Chief Corp Dev.&Strat. Officer | Grant or award · Stock Option (Right to Buy) | +91,655 | 91,655 | ||
| 2023-01-06 | Paggiarino Dario A. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +91,655 | 91,655 | ||
| 2022-11-01 | Duker Jay S. Chief Operating Officer | Option exercise | +15,258 | 25,881 | ||
| 2022-11-01 | Duker Jay S. Chief Operating Officer | Shares withheld for taxes | −4,479 | $5.42 | $24K | 21,402 |
| 2022-11-01 | Duker Jay S. Chief Operating Officer | Option exercise · Restricted Stock Units | −15,258 | 0 | ||
| 2022-09-07 | Duker Jay S. Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +65,300 | 65,300 | ||
| 2022-07-11 | Zaderej Karen L. Director | Grant or award · Restricted Stock Units | +6,000 | 6,000 | ||
| 2022-07-11 | Zaderej Karen L. Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 |
Page 26 of 31 · 616 trades